TP53 and breast carcinoma: An in vitro and in vivo study on the triterpenoid saponin platycodin D demonstrated its ability to inhibit cell growth in human breast cancer MDA-MB-231 cells by suppressing MDM2 and MDMX, and by reducing mutant p53 expression levels (Kong et al., 2016[104]).